Rebounding stocks: Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) up 8.67% Accenture PLC (NYSE:ACN) AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)
Northern, WI 04/19/2013 (GDPInsider) – Accenture PLC (NYSE:ACN) opened at $75.39 and is currently trading down at 1.10%. The modest slip is nothing too alarming given the trading day’s range of $74.21 – $75.39. The stock is in relatively healthy territory given the fact that the 52-week trading range is actually $54.94 and $78.46. At current trading it means that the stock is only down 3.91% on its 52-week high. With a RSI of 43.80 and a positive EPS of $4.29, investors can take the plunge without need for too much worry. The current trading value sees Accenture’s stock just dipping 1.24% below the 50-day moving average. The stock has also been receiving steady “buy” ratings from several key analysts and news that the company has launched a “Center of Excellence” aimed at helping companies reduce the cost of implementing software systems; the stock looks a solid buy going forward. Rounding out the soundness of the stock is market cap of $48.59 billion.
Is ACN a solid investment at these levels? Find out here.
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) is up a solid 8.67% or $0.2290 and is currently trading at $2.8860 a share. Acura opened at $2.74 and the stock has a current trading range of $2.65 and $2.95. Given the day’s opening value, Acura looks a solid offer for anyone looking to capitalize on small swings. The stock’s 52-week trading range of $1.06 and $4.50 means that current trading is down 39% on the 52-week high but a great improvement on its lowest recorded mark. Investors no doubt see this as a positive move and the trading value and volume duly reflects this. Today’s volume is a healthy 870,405 and the stock is 19.13% above the 50-day moving average of $2.30. Acura may be small cap at $134 million but the stock has been a beneficiary of a recent FDA decision. The stock chart saw a 50% breakout on the news and although there’s currently a negative EPS of $0.20, analysts expect things to liven up in the coming months.
How Should Investors Trade ACUR Now? Find out here.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) opened at $7.37 and is presently trading down 47.66% on the 52-week high of $14.08. The trading range for the stock is presently $7.31 and $7.55, a range which sees more than 1,154,360 shares changing hands. Things look marginally steady over time for the stock and the current trading value of $7.37 means AVEO is hovering slightly above its 50-day moving average of $7.25. AVEO Pharmaceuticals’ chart for the last 3 months has seen peaks and troughs but things seem to steadying for the month of April. The RSI for the stock is 5.34 and the stock currently has a negative EPS of $2.64. Analysts seem divided on the stock but a few of issued a “sell” rating. News that the stock is now been covered by JMP Securities a few weeks ago means that more people will be watching. Investors should therefore have enough data and sentiment to decide on whether to jump in. Losses for FY2012 were $21,480 but this figure showed a decline in losses over the previous year of $30,122.
How Should Investors Trade AVEO Now? Find out here.